The Personalized NSAID Therapeutics Consortium

The Personalized NSAID Therapeutics Consortium (PENTACON) is a group of 42 scientists from 22 institutions who have decided to test whether a paradigm for the personalization of drug treatment can be successfully developed. They have applied for funding through the National Institute of General Medical Sciences (NIGMS) GLUE grant mechanism.